# Johnson & Johnson (JNJ) — Q3-2025 Earnings Results

**Report date:** 2025-10-14 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2025

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Reaction N/A

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.80 | N/A | +0.94% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to long-term growth. They acknowledged ongoing market challenges but remained cautiously optimistic about future performance.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on long-term growth despite current market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Johnson & Johnson's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the lack of revenue data and guidance leaves some uncertainty about future performance. The stock reaction is currently unavailable, which may reflect investor caution amidst broader market conditions.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2025_